Validation group | Total regions or patients (n) | No. confirmed | No. ruled out | PPV or sensitivity |
---|---|---|---|---|
PPV | ||||
Histopathologic validation | ||||
PET-positive (per patient) | 27 | 27 (100%) | 0 (0%) | 1.00 (95% CI, 0.87 to 1.00) |
PET-positive (per region) | 33 | 32 (97%) | 1 (3%) | 0.97 (95% CI, 0.84 to 1.00) |
Sensitivity | ||||
Histopathologic findings | ||||
Confirmed (per patient) | 28 | 27 (96%)* | 1 (4%)† | 0.96 (95% CI, 0.82 to 1.00) |
Confirmed (per region) | 34 | 32 (94%)* | 2 (6%)† | 0.94 (95% CI, 0.80 to 0.99) |
*PET-positive.
↵†PET-negative.